Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
Go back to Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management| (NYSE: STVN) | Delayed: 17.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.25 | 52 Week High | $ | |||
| Open | $17.25 | 52 Week Low | $ | |||
| Day High | $17.25 | P/E | N/A | |||
| Day Low | $17.25 | EPS | $ | |||
| Volume | 290 | |||||
